Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer

Irinotecan is a key chemotherapeutic agent for the treatment of colorectal (CRC) and pancreatic (PDAC) cancer. Because of a high incidence of bone marrow and gastrointestinal (GI) toxicity, Onivyde® (a liposome) was introduced to provide encapsulated irinotecan (Ir) delivery in PDAC patients. While...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :ACS Nano
Главные авторы: Liu, Xiangsheng, Jiang, Jinhong, Chan, Ryan, Ji, Ying, Lu, Jianqin, Liao, Yu-Pei, Okene, Michael, Lin, Joshua, Lin, Paulina, Chang, Chong Hyun, Wang, Xiang, Tang, Ivanna, Zheng, Emily, Qiu, Waveley, Wainberg, Zev A., Nel, Andre E., Meng, Huan
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554030/
https://ncbi.nlm.nih.gov/pubmed/30525443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsnano.8b06164
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы